(Health-NewsWire.Net, May 20, 2016 ) Publisher's, 'Overactive Bladder - Pipeline Review, H1 2016', provides an overview of the Overactive Bladder pipeline landscape.
The report provides comprehensive information on the therapeutics under development for Overactive Bladder, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Overactive Bladder and features dormant and discontinued projects.
Publisher's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Publisher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.
Other Key Points in Report:
- The report provides a snapshot of the global therapeutic landscape of Overactive Bladder - The report reviews pipeline therapeutics for Overactive Bladder by companies and universities/research institutes based on information derived from company and industry-specific sources - The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages - The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved Overactive Bladder therapeutics and enlists all their major and minor projects - The report assesses Overactive Bladder therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
Inquire before Purchasing Report @ http://www.reportsweb.com/inquiry&RW0001239334/buying
Reasons to Buy
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Identify and understand important and diverse types of therapeutics under development for Overactive Bladder - Identify potential new clients or partners in the target demographic - Develop strategic initiatives by understanding the focus areas of leading companies - Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics - Devise corrective measures for pipeline projects by understanding Overactive Bladder pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Ask for Sample Report @ http://www.reportsweb.com/inquiry&RW0001239334/sample
Table of Content: An Overview
Introduction 9 Publisher Report Coverage 9 Overactive Bladder Overview 10 Therapeutics Development 11 Pipeline Products for Overactive Bladder - Overview 11 Pipeline Products for Overactive Bladder - Comparative Analysis 12 Overactive Bladder - Therapeutics under Development by Companies 13 Overactive Bladder - Therapeutics under Investigation by Universities/Institutes 15 Overactive Bladder - Pipeline Products Glance 16 Late Stage Products 16 Clinical Stage Products 17 Early Stage Products 18 Overactive Bladder - Products under Development by Companies 19 Overactive Bladder - Products under Investigation by Universities/Institutes 21 Overactive Bladder - Companies Involved in Therapeutics Development 22 Addex Therapeutics Ltd 22 Asahi Kasei Pharma Corp. 23 Astellas Pharma Inc. 24
Ask for Discount on Report @ http://www.reportsweb.com/inquiry&RW0001239334/discount
Dompe Farmaceutici S.p.A. 25 FemmePharma Global Healthcare, Inc. 26 Hydra Biosciences, Inc. 27 Ion Channel Innovations, LLC 28 Jeil Pharmaceutical Co., Ltd. 29 Juniper Pharmaceuticals, Inc. 30 Lipella Pharmaceuticals, Inc. 31 Merck & Co., Inc. 32 Mezzion Pharma Co. Ltd. 33 MI.TO. Technology S.r.L. 34 Recordati S.p.A. 35 Sanofi 36 Sihuan Pharmaceutical Holdings Group Ltd. 37 Taris Biomedical LLC 38 TheraVida, Inc. 39 Toray Industries, Inc. 40 UroGen Pharmaceuticals, Ltd. 41 Overactive Bladder - Therapeutics Assessment 42 Assessment by Monotherapy Products 42 Assessment by Combination Products 43 Assessment by Target 44 Assessment by Mechanism of Action 46 Assessment by Route of Administration 48 Assessment by Molecule Type 50
Purchase Complete Report @ http://www.reportsweb.com/buy&RW0001239334/buy/2000
About Us:
ReportsWeb.com is a one stop shop of market research reports and solutions to various companies across the globe. We help our clients in their decision support system by helping them choose most relevant and cost effective research reports and solutions from various publishers. We provide best in class customer service and our customer support team is always available to help you on your research queries.
Contact Us: Email: sales@reportsweb.com Call: +1-646-491-9876
ReportsWeb.com
Priya Sisodia
+1-646-491-9876
sales@reportsweb.com
Source: EmailWire.Com
|